Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis. A comparative study

Frontiers in Immunology

Volumn 4, Issue DEC, 2013, Pages

  Toussirot, Éric ^a,b,c,d   Grandclément, Émilie ^a,e   Gaugler, Béatrice ^b,d,f,g   Michel, Fabrice ^a   Wendling, Daniel ^a,c   Saas, Philippe ^a,b,d,f,g   Dumoulin, Gilles ^a,e  

^a UNIVERSITY HOSPITAL OF BESANÇON   (France)

^b UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^c Hôpital Saint Jacques   (France)

^d ANR 11 LABX 0021   (France)

^e Bâtiment Socrate   (France)

^f INSERM   (France)

^g ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

Adiponectin; Body composition; Cardiovascular risk; Fat mass; Leptin; Visceral fat

Indexed keywords

EID: 84892150505     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00453     Document Type: Article

References (40)

1. Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatology (Oxford) (2004) 43:1219-23. doi:10.1093/rheumatology/keh321
2. Marcora S, Casanova F, Williams E, Jones J, Elamanchi R, Lemmey A. Preliminary evidence for cachexia in patients with well-established ankylosing spondylitis. Rheumatology (Oxford) (2006) 45:1385-8. doi:10.1093/rheumatology/kel127
3. Toussirot E, Michel F, Wendling D. Bone density, ultrasound measurements and body composition in early ankylosing spondylitis. Rheumatology (Oxford) (2001) 40:882-8. doi:10.1093/rheumatology/40.8.882
4. Roubenoff R, Roubenoff RA, Ward LM, Holland SM, Hellmann DB. Rheumatoid cachexia: depletion of lean body mass in rheumatoid arthritis. Possible association with tumor necrosis factor. J Rheumatol (1992) 19:1505-10.
5. del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum (2001) 44:2737-45. doi:10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-#
6. Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 288:1401-4. doi:10.1136/bmj.288.6428.1401
7. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res (2005) 96:939-49. doi:10.1161/01.RES.0000163635.62927.34
8. Kaul S, Rothney MP, Peters DM, Wacker WK, Davis CE, Shapiro MD, et al. Dual-energy X-ray absorptiometry for quantification of visceral fat. Obesity (Silver Spring) (2012) 20:1313-8. doi:10.1038/oby.2011.393
9. Despres JP. Body fat distribution and risk of cardiovascular disease: an update. Circulation (2012) 126:1301-13. doi:10.1161/CIRCULATIONAHA.111.067264
10. Rajala MW, Scherer PE. Minireview: the adipocyte-at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology (2003) 144:3765-73. doi:10.1210/en.2003-0580
11. Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem (2007) 14:1095-100. doi:10.2174/092986707780362826
12. Krysiak R, Handzlik-Orlik G, Okopien B. The role of adipokines in connective tissue diseases. Eur J Nutr (2012) 51:513-28. doi:10.1007/s00394-012-0370-0
13. Ferraccioli G, Gremese E. Adiposity, joint and systemic inflammation: the additional risk of having a metabolic syndrome in rheumatoid arthritis. Swiss Med Wkly (2011) 141:w13211. doi:10.4414/smw.2011.13211
14. Toussirot E, Binda D, Gueugnon C, Dumoulin G. Adiponectin in autoimmune diseases. Curr Med Chem (2012) 19:5474-80. doi:10.2174/092986712803833119
15. Ouchi N, Walsh K. Adiponectin as an anti-inflammatory factor. Clin Chim Acta (2007) 380:24-30. doi:10.1016/j.cca.2007.01.026
16. Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, et al. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care (2006) 29:1357-62. doi:10.2337/dc05-1801
17. Otero M, Nogueiras R, Lago F, Dieguez C, Gomez-Reino JJ, Gualillo O. Chronic inflammation modulates ghrelin levels in humans and rats. Rheumatology (Oxford) (2004) 43:306-10. doi:10.1093/rheumatology/keh055
18. Stavropoulos-Kalinoglou A, Metsios GS, Koutedakis Y, Kitas GD. Obesity in rheumatoid arthritis. Rheumatology (Oxford) (2011) 50:450-62. doi:10.1093/rheumatology/keq266
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum (1988) 31:315-24. doi:10.1002/art.1780310302
20. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum (1984) 27:361-8. doi:10.1002/art.1780270401
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia (1985) 28:412-9. doi:10.1007/BF00280883
22. Toussirot E, Salmon C, Penfornis A, Wendling D. Precision evaluation of Lunar iDXA body composition measurements. J Bone Miner Res (2007) 22(Suppl):S300.
23. Book C, Karlsson MK, Akesson K, Jacobsson LT. Early rheumatoid arthritis and body composition. Rheumatology (Oxford) (2009) 48:1128-32. doi:10.1093/rheumatology/kep165
24. Giles JT, Ling SM, Ferrucci L, Bartlett SJ, Andersen RE, Towns M, et al. Abnormal body composition phenotypes in older rheumatoid arthritis patients: association with disease characteristics and pharmacotherapies. Arthritis Rheum (2008) 59:807-15. doi:10.1002/art.23719
25. Westhovens R, Nijs J, Taelman V, Dequeker J. Body composition in rheumatoid arthritis. Br J Rheumatol (1997) 36:444-8. doi:10.1093/rheumatology/36.4.444
26. Dao HH, Do QT, Sakamoto J. Abnormal body composition phenotypes in Vietnamese women with early rheumatoid arthritis. Rheumatology (Oxford) (2011) 50:1250-8. doi:10.1093/rheumatology/ker004
27. Giles JT, Bartlett SJ, Andersen R, Thompson R, Fontaine KR, Bathon JM. Association of body fat with C-reactive protein in rheumatoid arthritis. Arthritis Rheum (2008) 58:2632-41. doi:10.1002/art.23766
28. Toussirot E, Nguyen NU, Dumoulin G, Aubin F, Cedoz JP, Wendling D. Relationship between growth hormone-IGF-I-IGFBP-3 axis and serum leptin levels with bone mass and body composition in patients with rheumatoid arthritis. Rheumatology (Oxford) (2005) 44:120-5. doi:10.1093/rheumatology/keh421
29. Schakman O, Kalista S, Barbe C, Loumaye A, Thissen JP. Glucocorticoid-induced skeletal muscle atrophy. Int J Biochem Cell Biol (2013) 45:2163-72. doi:10.1016/j.biocel.2013.05.036
30. Dos Santos FP, Constantin A, Laroche M, Destombes F, Bernard J, Mazieres B, et al. Whole body and regional bone mineral density in ankylosing spondylitis. J Rheumatol (2001) 28:547-9.
31. Sari I, Demir T, Kozaci LD, Akar S, Kavak T, Birlik M, et al. Body composition, insulin, and leptin levels in patients with ankylosing spondylitis. Clin Rheumatol (2007) 26:1427-32. doi:10.1007/s10067-006-0509-6
32. Plasqui G, Boonen A, Geusens P, Kroot EJ, Starmans M, van der Linden S. Physical activity and body composition in patients with ankylosing spondylitis. Arthritis Care Res (Hoboken) (2012) 64:101-7. doi:10.1002/acr.20566
33. Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ, et al. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 65:1198-201. doi:10.1136/ard.2005.046540
34. Toussirot E, Streit G, Nguyen NU, Dumoulin G, Le Huede G, Saas P, et al. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Metabolism (2007) 56:1383-9. doi:10.1016/j.metabol.2007.05.009
35. Kocabas H, Kocabas V, Buyukbas S, Melikoglu MA, Sezer I, Butun B. The serum levels of resistin in ankylosing spondylitis patients: a pilot study. Rheumatol Int (2012) 32:699-702. doi:10.1007/s00296-010-1651-7
36. Klein-Wieringa IR, van der Linden MP, Knevel R, Kwekkeboom JC, van Beelen E, Huizinga TW, et al. Baseline serum adipokine levels predict radiographic progression in early rheumatoid arthritis. Arthritis Rheum (2011) 63:2567-74. doi:10.1002/art.30449
37. Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, et al. Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum (2009) 60:1906-14. doi:10.1002/art.24626
38. Giles JT, Allison M, Bingham CO III, Scott WM Jr, Bathon JM. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum (2009) 61:1248-56. doi:10.1002/art.24789
39. Ebert T, Roth I, Richter J, Tönjes A, Kralish S, Lossner U, et al. Different assoication of adipokines in lean and healthy adults. Horm Metab Res (2013). [Epub ahead of print].
40. Bucci L, Yani SL, Fabbri C, Bijlsma AY, Maier AB, Meskers CG, et al. Circulating levels of adipokines and IGF-I are associated with skeletal muscle strength of young and old healthy subjects. Biogerontology (2013) 14:261-72. doi:10.1007/s10522-013-9428-5